The Rise and Rise of the Oncology Market
Posted on Wed, Sep 02, 2009 @ 04:25 PM
The New York Times had a great story today by Andrew Pollack about the 
continuous push by Big Pharma and smaller specialty companies to become major players in oncology.
The article focuses mainly on Pfizer and the significant investments that the company is making in oncology--a major shift in strategy for the company, which historically has mainly focused its R&D efforts in other therapeutic areas.
The Healthcare PR Blog wrote about the explosive growth of the oncology market, and the fact that this trend looks set to continue in the years ahead, back in June of this year.
Check out the New York Times story and The Healthcare PR Blog entry from June. There are some very interesting forecasts and figures in both pieces.